Captopril alleviates vascular endothelial dysfunction by regulating TRPV1 and activating the eNOS pathway
{{output}}
Background: Vascular endothelial dysfunction (VED) underlies the pathogenesis of diabetic cardiovascular complications. Captopril (CAP), an angiotensin-converting enzyme inhibitor widely used in clinical practice, remains poorly ... ...
